Literature DB >> 1641444

HIV infection treatment costs under Medicaid in Michigan.

D J Solomon1, A J Hogan.   

Abstract

The Michigan Medicaid Program payment records generated in the period 1985-89 by 783 persons were analyzed for services related to human immunodeficiency virus (HIV) infection. Other data from death records and the Michigan AIDS Surveillance Registry were available for a subset of those persons. The average monthly payment in 1989 dollars for HIV-related services was $1,302.57. Services determined to be unrelated to HIV infection accounted for 12.5 percent of the total amount for health care received and another 2.5 percent was questionable. The average monthly expenditure for men was roughly twice that for women. The discrepancy did not exist among persons identified in the AIDS Surveillance Registry. Sex differences ceased to exist when Medicaid eligibility (disability versus Aid to Families with Dependent Children) was controlled for by analysis of variance. There were no significant differences between payments to those infected through male-to-male sexual contact and those infected through intravenous drug use. Payments for HIV treatments rose with age to about 40 years, and declined slightly among older adults. The sharpest rise was for those ages 19-25 years and 26-35 years. Large sex differences existed among those who received zidovudine (AZT), 61.4 percent of the men and 19.1 percent of the women. Controlling for Medicaid eligibility moderated those differences, but they remained statistically significant. Differences in zidovudine usage were not found between men and women in the subset identified in the AIDS Surveillance Registry nor among persons infected through male-to-male sexual contact and intravenous drug use.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641444      PMCID: PMC1403678     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  15 in total

1.  Under-utilization of medical care services by HIV-infected women? Some preliminary results from the Michigan Medicaid Program.

Authors:  A J Hogan; D J Soloman; R R Bouknight; C T Soloman
Journal:  AIDS       Date:  1991-03       Impact factor: 4.177

2.  Early treatment for HIV: the time has come.

Authors:  G H Friedland
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

3.  Updated forecasts of the costs of medical care for persons with AIDS, 1989-93.

Authors:  F J Hellinger
Journal:  Public Health Rep       Date:  1990 Jan-Feb       Impact factor: 2.792

4.  Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.

Authors:  A W Wu; W C Mathews; L T Brysk; J H Atkinson; I Grant; I Abramson; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Analysis of Michigan Medicaid costs to treat HIV infection.

Authors:  D J Solomon; A J Hogan; R R Bouknight; C T Solomon
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

Review 6.  The epidemiology of the human immunodeficiency virus.

Authors:  T C Quinn
Journal:  Ann Emerg Med       Date:  1990-03       Impact factor: 5.721

7.  Survival trends for patients with AIDS.

Authors:  G F Lemp; S F Payne; D Neal; T Temelso; G W Rutherford
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

8.  Epidemiology of AIDS in women in the United States. 1981 through 1986.

Authors:  M E Guinan; A Hardy
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

9.  Forecasting the medical care costs of the HIV epidemic: 1991-1994.

Authors:  F J Hellinger
Journal:  Inquiry       Date:  1991       Impact factor: 1.730

10.  Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons.

Authors:  M D Stein; J Piette; V Mor; T J Wachtel; J Fleishman; K H Mayer; C C Carpenter
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

View more
  4 in total

1.  Longitudinal patterns of medical service use and costs among people with AIDS.

Authors:  J A Fleishmann; V Mor; L L Laliberte
Journal:  Health Serv Res       Date:  1995-08       Impact factor: 3.402

2.  Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS.

Authors:  Mari M Kitahata; Stephen E Van Rompaey; Peter W Dillingham; Thomas D Koepsell; Richard A Deyo; Wayne Dodge; Edward H Wagner
Journal:  J Gen Intern Med       Date:  2003-02       Impact factor: 5.128

3.  AIDS treatment costs during the last months of life: evidence from the ACSUS.

Authors:  F J Hellinger; J A Fleishman; D C Hsia
Journal:  Health Serv Res       Date:  1994-12       Impact factor: 3.402

Review 4.  Patterns of Medicaid expenditures after AIDS diagnosis.

Authors:  L E Markson; L McKee; J Mauskopf; R Houchens; T R Fanning; B J Turner
Journal:  Health Care Financ Rev       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.